Global Cardiac Resynchronization Therapy Market By Segmentation - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2033
In 2022, the market for Cardiac Resynchronization Therapy worldwide was worth $ 4.80 billion US dollars. We Market projects that the market will reach $ 7.20 billion by 2033, growing at a CAGR of 5.3 percent between 2022 and 2033.
Cardiac Resynchronization Therapy (CRT), also known as biventricular pacing, is a medical treatment for heart failure. It involves implanting a device similar to a pacemaker, called a CRT device, which sends electrical signals to the heart to help synchronize the contractions of the heart's two lower chambers, the left and right ventricles. This synchronization can improve the efficiency of the heart's pumping action, leading to improved blood flow and reduced symptoms of heart failure.
Get the report with Full Information: - https://wemarketresearch.com/r....eports/cardiac-resyn
